Back
GRAIL 10K Form
Sell
14
GRAL
GRAIL
Last Price:
$18.38
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GRAL News And Ratings
See the #1 stock for the next 7 days that we like better than GRAL
GRAL Financial Statistics
Sales & Book Value
| Annual Sales: | $93.1M |
|---|---|
| Cash Flow: | $-105.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $77.93 |
| Price / Book: | 0.24 |
Profitability
| EPS (TTM): | -60.53690 |
|---|---|
| Net Income (TTM): | $-1.9B |
| Gross Margin: | $-95.6M |
| Return on Equity: | -81.16% |
| Return on Assets: | -50.05% |
GRAIL Earnings Forecast
Key GRAIL Financial Ratios
-
The Gross Profit Margin over the past 2 years for GRAL is -102.69%.
-
The Selling, General & Administrative Expenses for GRAL have been equal to 389.41% of Gross Profit Margin.
-
The Research & Development expenses have been 363.83% of Revenue.
-
The Net Earning history of GRAL is -1,378.71% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 2 years.
GRAIL Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GRAL |
| Website: | grail.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.65 |
| Quick Ratio: | 9.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |